RWE can provide insight on an entire treatment pathway, whereas an RCT can typically only focus on a single line. This evidence may be used to: aid in the refinement of patient care and clinical pathway design overcome data gaps inform clinical decision-making support RCT data in licensing and market authorisation applications Click here to find out more […]
Read MoreMonthly Archives: September 2019
RWD Shows Treatment Effectiveness with 30,000 Patients
Swedish researchers investigated whether there were any clinically meaningful differences between anti-psychotic medications’ effectiveness in treating schizophrenia A RWD database was used to carry out the nationwide study RWE allowed the study to find the treatments most likely to prevent relapses Click here to see the source article About SVMPharma SVMPharma is an innovative strategic consultancy, specialising in […]
Read MoreOncology RWE – Electronic Prescribing Records Chart Note Study
RWE Oncology Electronic Prescribing Records provide a unique opportunity to conduct large scale chart note reviews within all NHS hospitals in the UK SVMPharma Oncology Electronic Prescribing Records Chart notes have studied more than 6,000 patients in multiple tumour sites (prostate cancer, renal cell carcinoma, ovarian cancer, and lung cancer) Oncology Electronic Prescribing Records provide […]
Read More